SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-17-302133
Filing Date
2017-10-03
Accepted
2017-10-03 16:03:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C d469354dsc14d9c.htm SC14D9C 11837
2 EX-99.1 d469354dex991.htm EX-99.1 6953
3 EX-99.2 d469354dex992.htm EX-99.2 6505
  Complete submission text file 0001193125-17-302133.txt   26932
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filed by) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Subject) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-89163 | Film No.: 171117784
SIC: 2836 Biological Products, (No Diagnostic Substances)